Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1982 Sep;9(3):253–266.

Cyclosporin A: A New Advance in Transplantation

B D Kahan 1
PMCID: PMC351624  PMID: 15226925

Abstract

Cyclosporin A (CyA)* has been shown to be a cytostatic drug with apparent specificity for the immune system. At clinical trials, an analysis of the patients showed marked immunosuppressive potency of CyA.

This selective anti-T cell agent is described in detail, with studies showing the immunological effects of graft survival in renal transplant patients.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin W. M., 3rd, Hutchinson I. F., Meijer C. J., Tilney N. L. Immune responses to organ allografts. III. Marked decrease in medullary thymocytes and splenic T lymphocytes after cyclosporin A treatment. Transplantation. 1981 Feb;31(2):117–120. [PubMed] [Google Scholar]
  2. Borel J. F. Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology. 1976 Oct;31(4):631–641. [PMC free article] [PubMed] [Google Scholar]
  3. Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
  4. Borel J. F. Immunosuppressive properties of cyclosporin A (CY-A). Transplant Proc. 1980 Jun;12(2):233–233. [PubMed] [Google Scholar]
  5. Burckhardt J. J., Guggenheim B. Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function. Immunology. 1979 Apr;36(4):753–757. [PMC free article] [PubMed] [Google Scholar]
  6. Calne R. Y. Pharmacological immunosuppression in clinical organ grafting. Observations on four agents: cyclosporin A, Asta 5122 (cytimun), lambda carrageenan and promethazine hydrochloride. Clin Exp Immunol. 1979 Jan;35(1):1–9. [PMC free article] [PubMed] [Google Scholar]
  7. Calne R. Y., Rolles K., White D. J., Thiru S., Evans D. B., McMaster P., Dunn D. C., Craddock G. N., Henderson R. G., Aziz S. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979 Nov 17;2(8151):1033–1036. doi: 10.1016/s0140-6736(79)92440-1. [DOI] [PubMed] [Google Scholar]
  8. Cosimi A. B., Colvin R. B., Burton R. C., Rubin R. H., Goldstein G., Kung P. C., Hansen W. P., Delmonico F. L., Russell P. S. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med. 1981 Aug 6;305(6):308–314. doi: 10.1056/NEJM198108063050603. [DOI] [PubMed] [Google Scholar]
  9. Deeg H. J., Storb R., Gerhard-Miller L., Shulman H. M., Weiden P. L., Thomas E. D. Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance. Transplantation. 1980 Mar;29(3):230–235. doi: 10.1097/00007890-198003000-00014. [DOI] [PubMed] [Google Scholar]
  10. Gordon M. Y., Singer J. W. Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man. Nature. 1979 May 31;279(5712):433–434. doi: 10.1038/279433a0. [DOI] [PubMed] [Google Scholar]
  11. Hess A. D., Tutschka P. J. Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR. J Immunol. 1980 Jun;124(6):2601–2608. [PubMed] [Google Scholar]
  12. Kahan B. D., Van Buren C. T., Lin S. N., Ono Y., Agostino G., LeGrue S. J., Boileau M., Payne W. D., Kerman R. H. Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts. Transplantation. 1982 Jul;34(1):36–45. doi: 10.1097/00007890-198207000-00007. [DOI] [PubMed] [Google Scholar]
  13. Keown P. A., Stiller C. R., Ulan R. A., Sinclair N. R., Wall W. J., Carruthers G., Howson W. Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet. 1981 Mar 28;1(8222):686–689. doi: 10.1016/s0140-6736(81)91971-1. [DOI] [PubMed] [Google Scholar]
  14. Klintmalm G. B., Iwatsuki S., Starzl T. E. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation. 1981 Dec;32(6):488–489. doi: 10.1097/00007890-198112000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Klintmalm G. B., Iwatsuki S., Starzl T. E. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation. 1981 Dec;32(6):488–489. doi: 10.1097/00007890-198112000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Larsson E. L. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol. 1980 Jun;124(6):2828–2833. [PubMed] [Google Scholar]
  17. Leapman S. B., Filo R. S., Smith E. J., Smith P. G. In vitro effects of cyclosporin A on lymphocyte subpopulations. 1. Suppressor cell sparing by cyclosporin A. Transplantation. 1980 Dec;30(6):404–408. doi: 10.1097/00007890-198012000-00003. [DOI] [PubMed] [Google Scholar]
  18. Molinaro G. A., Maron E., Dray S. Antigen-secreting cells: enumeration of immunoglobulin-allotype-secreting cells in nonimmunized rabbits by means of hybrid-antibody-coated erythrocytes in a reverse hemolytic plaque assay. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1229–1233. doi: 10.1073/pnas.71.4.1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Niederberger W., Schaub P., Beveridge T. High-performance liquid chromatographic determination of cyclosporin A in human plasma and urine. J Chromatogr. 1980 Jun 13;182(3-4):454–458. doi: 10.1016/s0378-4347(00)81500-5. [DOI] [PubMed] [Google Scholar]
  20. Paavonen T., Häyry P. Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro. Nature. 1980 Oct 9;287(5782):542–544. doi: 10.1038/287542a0. [DOI] [PubMed] [Google Scholar]
  21. Palacios R., Möller G. T cell growth factor abrogates concanavalin A-induced suppressor cell function. J Exp Med. 1981 May 1;153(5):1360–1365. doi: 10.1084/jem.153.5.1360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Petcher T. J., Weber H., Rüegger A. Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A. Helv Chim Acta. 1976 Jun 14;59(5):1480–1489. doi: 10.1002/hlca.19760590509. [DOI] [PubMed] [Google Scholar]
  23. Rodbard D., Lewald J. E. Computer analysis of radioligand assay and radioimmunoassay data. Acta Endocrinol Suppl (Copenh) 1970;147:79–103. doi: 10.1530/acta.0.065s079. [DOI] [PubMed] [Google Scholar]
  24. Routhier G., Epstein O., Janossy G., Thomas H. C., Sherlock, Kung P. C., Goldstein G. Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis. Lancet. 1980 Dec 6;2(8206):1223–1226. doi: 10.1016/s0140-6736(80)92481-2. [DOI] [PubMed] [Google Scholar]
  25. Ryffel B., Donatsch P., Götz U., Tschopp M. Cyclosporin receptor on mouse lymphocytes. Immunology. 1980 Dec;41(4):913–919. [PMC free article] [PubMed] [Google Scholar]
  26. Rüegger A., Kuhn M., Lichti H., Loosli H. R., Huguenin R., Quiquerez C., von Wartburg A. Cyclosporin A, ein immunsuppressiv wirksamer Peptidmetabolit aus Trichoderma polysporum (Link ex Pers.) Rifai. Helv Chim Acta. 1976;59(4):1075–1092. doi: 10.1002/hlca.19760590412. [DOI] [PubMed] [Google Scholar]
  27. Thomas J., Thomas F., Hoffmann S., Johns C., Lee H. M. Macrophage-related suppressor cells in human renal transplant recipients. Surgery. 1979 Aug;86(2):266–274. [PubMed] [Google Scholar]
  28. Van Buren C. T., Kerman R., Agostino G., Payne W., Flechner S., Kahan B. D. The cellular target of cyclosporin A action in humans. Surgery. 1982 Aug;92(2):167–174. [PubMed] [Google Scholar]
  29. White D. J., Plumb A. M., Pawelec G., Brons G. Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells. Transplantation. 1979 Jan;27(1):55–58. [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES